PO
Poolbeg Pharma PLC
POLBF · OTC
$0.10 +0.00% (+$0.00)
Market Cap £54.2M
P/E Ratio -
Div. Yield -
ROE 53.90%
Piotroski F-Score Weak
1/9Valuation
21 /100
Expensive P/B 6.30x
EV/FFO N/A
P/E N/A
Growth
0 /100
Declining Book val. growth 22.29%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 57.28%
ROIC 73.60%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 6.17x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
27 /100
Unstable Profitable years 0
Beta 1.81x
EPS volatility 37.15%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre POLBF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jeremy Skillington
Employees
15
Headquarters
London
Evenimente viitoare
04 MAR.
Earnings
Upcoming earnings report